Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pain 19 Neoplasms 18 Cancer Pain 6 Breast Neoplasms 5 Breakthrough Pain 5 Prostatic Neoplasms 4 Lung Neoplasms 4 Colonic Neoplasms 4 Agnosia 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Head and Neck Neoplasms 3 Chronic Pain 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain, Postoperative 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Burns 2 Anemia, Sickle Cell 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vipoma 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1

Interventions

apatinib 1 Yoga 1 Tamoxifen 1 Surveys and Questionnaires 1 Referral and Consultation 1 Fentanyl 1 Educational Status 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Quality of Life × Fentanyl × Clear all

NCT01936636 2015-11-05

RELIEF

Galena Biopharma, Inc.

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡